Duo helped Hovione, Portugal’s largest pharmaceutical company, protect sensitive intellectual property and confidential drug development data across five countries. By replacing weak username and password access with Duo’s trusted multi-factor authentication solution, Duo strengthened security and ensured only authorized users could access critical systems. This protection safeguarded proprietary information during drug development and licensing processes, helping Hovione maintain confidentiality and regulatory compliance while securing their valuable assets in a highly competitive industry.

Join for free to read